These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26421934)

  • 1. Association of interleukin-10 levels with age of onset and duration of illness in patients with major depressive disorder.
    Gazal M; Jansen K; Souza LD; Oses JP; Magalhães PV; Pinheiro R; Ghisleni G; Quevedo L; Kaster MP; Kapczinski F; da Silva RA
    Braz J Psychiatry; 2015; 37(4):296-302. PubMed ID: 26421934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-6 and Interleukin-10 in mood disorders: A population-based study.
    Wiener CD; Moreira FP; Portela LV; Strogulski NR; Lara DR; da Silva RA; Souza LDM; Jansen K; Oses JP
    Psychiatry Res; 2019 Mar; 273():685-689. PubMed ID: 31207853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are there differences in lipid peroxidation and immune biomarkers between major depression and bipolar disorder: Effects of melancholia, atypical depression, severity of illness, episode number, suicidal ideation and prior suicide attempts.
    Sowa-Kućma M; Styczeń K; Siwek M; Misztak P; Nowak RJ; Dudek D; Rybakowski JK; Nowak G; Maes M
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():372-383. PubMed ID: 28867391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melancholic and atypical major depression--connection between cytokines, psychopathology and treatment.
    Dunjic-Kostic B; Ivkovic M; Radonjic NV; Petronijevic ND; Pantovic M; Damjanovic A; Poznanovic ST; Jovanovic A; Nikolic T; Jasovic-Gasic M
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():1-6. PubMed ID: 23200828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory cytokines and functional impairment in drug-free subjects with mood disorder.
    Wiener CD; Moreira FP; Cardoso TA; Mondin TC; da Silva Magalhães PV; Kapczinski F; de Mattos Souza LD; da Silva RA; Oses JP; Jansen K
    J Neuroimmunol; 2017 Jun; 307():33-36. PubMed ID: 28495135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in the immune-inflammatory profiles of unipolar and bipolar depression.
    Brunoni AR; Supasitthumrong T; Teixeira AL; Vieira EL; Gattaz WF; Benseñor IM; Lotufo PA; Lafer B; Berk M; Carvalho AF; Maes M
    J Affect Disord; 2020 Feb; 262():8-15. PubMed ID: 31693974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional versus syndromal recovery in patients with major depressive disorder and bipolar disorder.
    van der Voort TY; Seldenrijk A; van Meijel B; Goossens PJ; Beekman AT; Penninx BW; Kupka RW
    J Clin Psychiatry; 2015 Jun; 76(6):e809-14. PubMed ID: 26132690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1β is associated with depressive episode in major depression but not in bipolar disorder.
    Mota R; Gazal M; Acosta BA; de Leon PB; Jansen K; Pinheiro RT; Souza LD; Silva RA; Oses JP; Quevedo L; Lara DR; Ghisleni G; Kaster MP
    J Psychiatr Res; 2013 Dec; 47(12):2011-4. PubMed ID: 24074516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sociodemographic and clinical features of bipolar disorder patients misdiagnosed with major depressive disorder in China.
    Xiang YT; Zhang L; Wang G; Hu C; Ungvari GS; Dickerson FB; Kilbourne AM; Si TM; Fang YR; Lu Z; Yang HC; Lai KY; Lee EH; Hu J; Chen ZY; Huang Y; Sun J; Wang XP; Li HC; Zhang JB; Chiu HF
    Bipolar Disord; 2013 Mar; 15(2):199-205. PubMed ID: 23437963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum level of nerve growth factor is a potential biomarker of conversion to bipolar disorder in women with major depressive disorder.
    Pedrotti Moreira F; Cardoso TC; Mondin TC; Wiener CD; de Mattos Souza LD; Oses JP; Jansen K; da Silva RA
    Psychiatry Clin Neurosci; 2019 Sep; 73(9):590-593. PubMed ID: 31170316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High concentrations of serum interleukin-6 and interleukin-8 in patients with bipolar disorder.
    Lu YR; Rao YB; Mou YJ; Chen Y; Lou HF; Zhang Y; Zhang DX; Xie HY; Hu LW; Fang P
    Medicine (Baltimore); 2019 Feb; 98(7):e14419. PubMed ID: 30762747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder.
    Kauer-Sant'Anna M; Kapczinski F; Andreazza AC; Bond DJ; Lam RW; Young LT; Yatham LN
    Int J Neuropsychopharmacol; 2009 May; 12(4):447-58. PubMed ID: 18771602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and humanistic impact of potential misdiagnosis of bipolar disorder among patients with major depressive disorder in a commercially insured population.
    Kamat SA; Rajagopalan K; Pethick N; Willey V; Bullano M; Hassan M
    J Manag Care Pharm; 2008 Sep; 14(7):631-42. PubMed ID: 18774873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-episode hypomanic symptoms during major depression and their correlates.
    Benazzi F
    Psychiatry Clin Neurosci; 2004 Jun; 58(3):289-94. PubMed ID: 15149296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Undiagnosed bipolar disorder in patients treated for major depression in China.
    Hu C; Xiang YT; Ungvari GS; Dickerson FB; Kilbourne AM; Si TM; Fang YR; Lu Z; Yang HC; Chiu HF; Lai KY; Hu J; Chen ZY; Huang Y; Sun J; Wang XP; Li HC; Zhang JB; Wang G
    J Affect Disord; 2012 Oct; 140(2):181-6. PubMed ID: 22397888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune dysfunction in bipolar disorder and suicide risk: is there an association between peripheral corticotropin-releasing hormone and interleukin-1β?
    Monfrim X; Gazal M; De Leon PB; Quevedo L; Souza LD; Jansen K; Oses JP; Pinheiro RT; Silva RA; Lara DR; Ghisleni G; Spessato B; Kaster MP
    Bipolar Disord; 2014 Nov; 16(7):741-7. PubMed ID: 24862833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological rhythms in bipolar and depressive disorders: A community study with drug-naïve young adults.
    Duarte Faria A; Cardoso Tde A; Campos Mondin T; Souza LD; Magalhaes PV; Patrick Zeni C; Silva RA; Kapczinski F; Jansen K
    J Affect Disord; 2015 Nov; 186():145-8. PubMed ID: 26241662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory cytokines and nuclear factor-kappa B activation in adolescents with bipolar and major depressive disorders.
    Miklowitz DJ; Portnoff LC; Armstrong CC; Keenan-Miller D; Breen EC; Muscatell KA; Eisenberger NI; Irwin MR
    Psychiatry Res; 2016 Jul; 241():315-22. PubMed ID: 27227701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence and illness characteristics of DSM-5-defined "mixed feature specifier" in adults with major depressive disorder and bipolar disorder: Results from the International Mood Disorders Collaborative Project.
    McIntyre RS; Soczynska JK; Cha DS; Woldeyohannes HO; Dale RS; Alsuwaidan MT; Gallaugher LA; Mansur RB; Muzina DJ; Carvalho A; Kennedy SH
    J Affect Disord; 2015 Feb; 172():259-64. PubMed ID: 25451425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency and correlates of gambling problems in outpatients with major depressive disorder and bipolar disorder.
    Kennedy SH; Welsh BR; Fulton K; Soczynska JK; McIntyre RS; O'Donovan C; Milev R; le Melledo JM; Bisserbe JC; Zimmerman M; Martin N
    Can J Psychiatry; 2010 Sep; 55(9):568-76. PubMed ID: 20840804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.